Laura Stanley

Laura Stanley

Auto-generated profile, based on publicly available information

Laura Stanley

Computer Science, School of Computing, Montana State University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 April 2025 in IISE Transactions on Occupational Ergonomics and Human Factors
Verified
Journal Article
Closed access
HJHeejin Jeong
Heejin Jeong
KCKaren B. Chen
Karen B. Chen
Myounghoon JeonMyounghoon Jeon
Myounghoon Jeon
LSLaura Stanley
Laura Stanley

31 December 2025 in JMIR Preprints
Verified
Preprint
Open access
AZAshlyn Zebrowski
Ashlyn Zebrowski
JFJackson Fernandez
Jackson Fernandez
CPCameron Pinkelton
Cameron Pinkelton
RKRebecca Kitzmiller
Rebecca Kitzmiller
AKAdam W. Kiefer
Adam W. Kiefer
LMLukasz Mazur
Lukasz Mazur
BACKGROUND Digital therapeutics (DTx) are emerging as effective, evidence-based interventions for mental health conditions, serving as both complements to and alternatives to traditional treatments. Virtual reality (VR) has demonstrated particular promise as a delivery modality, leveraging immersion and engagement to enhance user experience and improve clinical outcomes. Despite growing evidence supporting VR-based digital therapeutics, little is known about the implementation strategies required to support widespread adoption by patients and clinicians. In particular, the fit of VR therapeutics within clinical workflows, including prescribing, onboarding, and delivery outside the clinic, remains insufficiently explored. OBJECTIVE This pilot randomized study evaluated how implementation materials and provider engagement impact acceptability, usability, and fidelity of VRx use in the non-clinical setting. Three experimental conditions were evaluated: (1) unguided VRx use, (2) self-directed VRx with assistive training materials, and (3) clinician-prescribed VRx with assistive training materials. METHODS Healthy adults (N=31) were randomized into three conditions: (1) VRx exposure without support, (2) VRx with self-directed training and assistive materials, or (3) VRx with provider-led instruction and prescription. A mixed-methods approach grounded in human factors was applied. Technology acceptance (TAM), usability (SUS), and engagement were assessed pre- and post-intervention. Observational methods captured user interaction patterns, including task completion rates, error frequency, help-seeking behaviors, and adaptation strategies. Qualitative feedback further contextualized usability challenges, perceived workload, and the role of support systems in shaping user confidence and adoption. RESULTS All groups showed significant increases in acceptance post-intervention (p<.001). Condition 3 demonstrated the strongest improvements across all acceptability measures and the highest engagement, with participants spending 99% of prescribed time in VRx. Provider interaction reinforced perceived safety, increased adherence, and enhanced willingness to adopt VRx. In contrast, training materials alone produced modest improvements, suggesting limited effectiveness without human guidance. CONCLUSIONS This is the first study to experimentally compare different implementation strategies for VRx adoption. Findings highlight the pivotal role of clinician involvement in improving acceptance, usability, and engagement. Structured instructional support and provider endorsement may be essential for scaling VRx and digital therapeutics in real-world care.

31 December 2025 in JMIR XR and Spatial Computing
Verified
Journal Article
Open access
AZAshlyn Zebrowski
Ashlyn Zebrowski
JFJackson Fernandez
Jackson Fernandez
CPCameron Pinkelton
Cameron Pinkelton
RKRebecca Kitzmiller
Rebecca Kitzmiller
AKAdam W. Kiefer
Adam W. Kiefer
LMLukasz Mazur
Lukasz Mazur
Virtual reality therapeutics (VRx) are emerging as a form of digital therapeutics (DTx) with growing evidence for improving symptoms such as anxiety, pain, and distress. However, real-world adoption remains limited because successful use depends not only on the therapeutic benefits but also on how the intervention is introduced, supported, and integrated into care, in addition to the therapeutic benefits. Existing literature has identified barriers related to clinician familiarity, prescribing pathways, onboarding, and independent use outside the clinic, but few studies have experimentally evaluated how implementation strategies influence early adoption outcomes. This feasibility pilot study evaluated how different implementation strategies influence early adoption of a VRx intervention in a nonclinical setting by comparing unguided VRx use, self-directed VRx use with implementation materials, and VRx use with prescriber-led consultation and support. An institutional review board–approved, 3-arm randomized feasibility pilot study was conducted following the Virtual Reality Clinical Outcomes Research Experts framework and reported using the CONSORT (Consolidated Standards of Reporting Trials) 2010 extension guidelines for pilot and feasibility studies. Participants were randomly allocated to 1 of 3 experimental conditions. Outcomes included technology acceptance, usability, fidelity, and tolerability. Quantitative measures were complemented by qualitative exit interviews. Analyses were exploratory, and the study was not powered for hypothesis testing. Across conditions, brief VRx exposure was associated with significant improvements in overall technology acceptance (P<.001), though postintervention scores remained in the neutral range, indicating early shifts rather than strong endorsement. Participants receiving provider-supported implementation demonstrated the most consistent pattern of favorable outcomes, including higher fidelity of use and significantly greater time-based adherence (P=.04). Usability scores were generally favorable across conditions. Tolerability was acceptable, with low levels of reported cybersickness and no discontinuations due to adverse effects. Qualitative findings highlighted the importance of guidance, expectation-setting, and perceived clinical legitimacy in shaping engagement. This study demonstrates that implementation strategy is a key determinant of adoption for virtual reality–based DTx. By experimentally isolating onboarding and provider support components, this work extends prior efficacy-focused research to address implementation design. Findings suggest that brief provider involvement and structured onboarding may enhance engagement and adherence, supporting future evaluation of scalable DTx implementation models in clinical and community settings.